XERS
Xeris Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.95
+6.21%Leverage
- Debt / equity
- -29.74x
- Net debt / equity
- -17.23x
- Debt / assets
- 0.70x
- Debt / EBITDA
- 17.45x
- Net debt / EBITDA
- 10.11x
Liquidity & coverage
- Current ratio
- 1.45x
- Quick ratio
- 1.02x
- Cash ratio
- 0.64x
- Interest coverage
- 1.30x
- EBITDA / interest
- 0.59x
- Working capital
- $85.2M
Cash & dividend
- FCF / debt
- 0.19x
- Cash flow / debt
- 0.20x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026